In cytokine release syndrome (CRS), the tumor cell DNA released by pyroptotic cells during CAR-T therapy is internalized by macrophages, activating the inflammasomes and releasing bioactive IL-1β, IL-18, and other pro-inflammatory cytokines [88]. This evidence concerns the gene IL18 and neoplasm.